Delivery Order SPE2DB20D3103-SPE2DB23FM6W3
Award Date
3/7/23
Potential Completion Date
3/8/23
Potential Value
$6.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,579.36 Firm Fixed Price Delivery Order is for the supply of Brimonidine Tartrate 0.15% eye drops, with a completion date of February 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Brimonidine Tartrate 0.15% eye drops in 15mL bottles to the Defense Logistics Agency (DLA). The $1,451.83 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 24, 2021. The contract has an ultimate completion date of September 27, 2021 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent...
This federal contract award, with the ID SPE2DB22D1052|SPE2DB24FU8LR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Brimonidine Tartrate 0.15% eye drops in 5 ml bottles. The contract is a Firm-Fixed-Price Delivery Order with a ceiling value of $4,459.28 and an ultimate completion date of February 12, 2024. The contract was not set aside for any specific business category....
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Brimonidine Tartrate 0.15% ophthalmic drops. The $1,957.02 firm fixed-price contract has an ultimate completion date of April 10, 2024. AmerisourceBergen is a for-profit organization that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,883.20 Firm Fixed Price Delivery Order covers the supply of Brimonidine Tartrate 0.15% eye drops, a medication used to treat glaucoma. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Brimonidine Tartrate 0.15% eye drops, a medication used to treat glaucoma. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,017.41 and a completion date of March 25, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Brimonidine Tartrate 0.15% Ophthalmic Drops, 10 mL, with a ceiling value of $1,091.13. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,989.30 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide brimonidine tartrate 0.1% eye drops. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,774.84 delivery order contract is for the supply of brimonidine tartrate 0.15% eye drops, a medication used to treat glaucoma. The contract is a Firm Fixed Price (FFP) delivery order that is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,103.07 firm fixed-price delivery order is for the supply of BRINZOLAMIDE 1% EYE DROPS 10ML, a pharmaceutical product. The contract has a period of performance through December 12, 2024 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...